Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2003
04/01/2003US6541485 Urea substituted imidazoquinolines
04/01/2003US6541484 Central nervous system disorders; psychological disorders
04/01/2003US6541483 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
04/01/2003US6541482 Autoimmune disease
04/01/2003US6541481 Substituted bicyclic derivatives useful as anticancer agents
04/01/2003US6541480 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor
04/01/2003US6541477 Inhibitors of p38-a kinase
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses.
04/01/2003US6541466 Such as 1-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)-aminodibenzosuberane; for treatment of Alzheimer's disease
03/2003
03/28/2003CA2405342A1 Methods of treatment and kits comprising a growth hormone secretagogue
03/27/2003WO2003024969A1 Tyrosine kinase inhibitors
03/27/2003WO2003024964A1 Tricyclic pyridin-2-one analogues as gaba-a receptor ligands
03/27/2003WO2003024963A2 Substituted imidazo[1, 2-a]-5, 6, 7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1, 2-a]pyridines
03/27/2003WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity
03/27/2003WO2003024949A1 Dna-pk inhibitors
03/27/2003WO2003024936A1 Substituted pyrazolo compounds for the treatment of inflammation
03/27/2003WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003WO2003024926A2 Methods and compositions of novel triazine compounds
03/27/2003WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
03/27/2003WO2003024401A2 Piperizinones as modulators of chemokine receptor activity
03/27/2003WO2002096318A3 Method for treating glaucoma v
03/27/2003WO2002060879A3 Bacterial gyrase inhibitors and uses thereof
03/27/2003WO2002048147A3 Pyrazolopyridines
03/27/2003WO2002026220A3 Taxoid conjugates as antimitotic and antitumor agents
03/27/2003WO2002014286A9 Preparation of risperidone
03/27/2003WO2001090109A9 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
03/27/2003US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative
03/27/2003US20030060494 Dipeptidyl peptidase IV inhibiting agent; treatment of gastrointestinal disorders
03/27/2003US20030060464 Therapeutic 1H-pyrido [ 4, 3-b ] indoles
03/27/2003US20030060462 Therapeutic compounds
03/27/2003US20030059369 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
03/27/2003CA2461074A1 Methods and compositions of novel triazine compounds
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003CA2459960A1 Substituted imidazo[1, 2-a]-5, 6, 7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1, 2-a]pyridines
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003WO2002026732A1 Benzodiazepine derivative
03/26/2003EP1295883A1 Medicines for the prevention and treatment of neurodegenerative diseases
03/26/2003EP1294823A1 Double-spiro organic compounds and electroluminescent devices
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294720A1 Non-nucleoside reverse transcriptase inhibitors
03/26/2003EP1294719A1 Melanocortin receptor ligands
03/26/2003EP1294718A2 6,5-fused bicyclic heterocycles
03/26/2003EP1294715A1 Quinazoline ditosylate salt compounds
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1175420B1 Process for preparing n6-substituted deaza-adenosine derivatives
03/26/2003EP1114043B1 Naphthopyrans annelated in c 6?-c 7?, their preparation and compositions and (co)polymer matrices containing them
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0970080B1 Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405167A Method for purifying diversine
03/26/2003CN1103775C Vitronectin receptor antagonists, their preparation and use
03/26/2003CN1103774C Imino-aza-anthracyclinone derivatives for the theatment of amyloidosis
03/26/2003CN1103773C 二氮杂萘衍生物 Naphthyridine derivative
03/26/2003CN1103769C Tricyclic amine derivatives
03/26/2003CA2423902A1 Benzodiazepine derivative
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003WO2002026260A1 Preventives/remedies for emotional disorders
03/25/2003US6538010 Compounds may be used to treat a variety of other conditions and disease states and reagents for preventing smoking addiction. The present invention also relates to methods and reagents for treating nicotine addiction.
03/25/2003US6538004 Potassium channel modulators relax smooth muscle cells and inhibit bladder contractions; treating nervous, eating, cardiovascular, gastrointestinal, and sexual disorders
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/25/2003US6537986 Oxazolidinone antibacterial agents having a thiocarbonyl funtionality
03/25/2003US6537964 The present invention describes the use of fumitremorgin A, B and C and a series of diketopiperazines of Formula (I) to resensitize multidrug resistant (MDR) cancer cells to the cytotoxic effects of chemotherapeutic drugs.
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2423364A1 Preventives/remedies for emotional disorders
03/25/2003CA2301599C Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
03/25/2003CA2237221C Protein kinase c inhibitor
03/21/2003WO2002022555A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
03/20/2003WO2003022849A1 Carbazole derivatives and their use as npy5 receptor antagonists
03/20/2003WO2003022846A1 1-glyoxlylamide indolizines for treating cancer
03/20/2003WO2003022845A1 Pyrazolo-pyridines for the treatment of herpes infections
03/20/2003WO2003022279A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022275A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
03/20/2003WO2003022274A2 2-aroylimidazole compounds for treating cancer
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003000011A3 Novel pyridopyrimidines and uses thereof
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002074910A3 Selective anti-viral nucleoside chain terminators
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002051810A3 Integrin receptor ligands
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002030886A3 Heterocyclic angiogenesis inhibitors
03/20/2003US20030055251 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
03/20/2003US20030055244 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
03/20/2003US20030055094 Bicyclic modulators of androgen receptor function
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 646